Evidence map›Paper›PMID 39995164›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2025

Systemic Inflammation and the Inflammatory Context of the Colonic Microenvironment Are Improved by Urolithin A.

Marmar R Moussa, Nuoxi Fan, John Birk, Anthony A Provatas, Pratik Mehta, Yuichiro Hatano, Ock K Chun, Manije Darooghegi Mofrad, Ali Lotfi, Alexander Aksenov and 6 more

Registry-linked trialAbstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05195970 (Microbiota, Metabolites and Colon Neoplasia), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05195970 nacompletednot on this map

Microbiota, Metabolites and Colon Neoplasia

TypeinterventionalSponsorUConn HealthRan2022 to 2026Enrolled140ConditionsColorectal Cancer, Diet HabitArmsWalnuts
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Marmar R Moussa *Center for Molecular Oncology, School of Medicine, University of Connecticut, Farmington, Connecticut.ORCID 0000-0003-0574-6656
Nuoxi Fan *Center for Molecular Oncology, School of Medicine, University of Connecticut, Farmington, Connecticut.ORCID 0009-0001-2636-0237
John BirkDivision of Gastroenterology, University of Connecticut, Farmington, Connecticut.ORCID 0000-0003-2717-0723
Anthony A ProvatasCenter for Environmental Sciences and Engineering, University of Connecticut, Storrs, Connecticut.ORCID 0000-0001-9091-3740
Pratik MehtaCenter for Molecular Oncology, School of Medicine, University of Connecticut, Farmington, Connecticut.ORCID 0000-0001-9085-738X
Yuichiro HatanoCenter for Molecular Oncology, School of Medicine, University of Connecticut, Farmington, Connecticut.ORCID 0000-0002-5121-6325
Ock K ChunDepartment of Nutritional Sciences, University of Connecticut, Storrs, Connecticut.ORCID 0000-0002-7391-2380
Manije Darooghegi MofradDepartment of Nutritional Sciences, University of Connecticut, Storrs, Connecticut.ORCID 0000-0003-3938-2299
Ali LotfiDepartment of Chemistry, University of Connecticut, Storrs, Connecticut.ORCID 0000-0001-6124-3338
Alexander AksenovDepartment of Chemistry, University of Connecticut, Storrs, Connecticut.ORCID 0000-0002-9445-2248
Vinicius N MottaStandard BioTools Canada Inc., Markham, Canada.ORCID 0009-0007-4551-1110
Maryam ZenaliCenter for Molecular Oncology, School of Medicine, University of Connecticut, Farmington, Connecticut.ORCID 0009-0005-9198-933X
Haleh VaziriDivision of Gastroenterology, University of Connecticut, Farmington, Connecticut.ORCID 0000-0002-1550-5496
James J GradyDepartment of Public Health Sciences, University of Connecticut, Storrs, Connecticut.ORCID 0000-0003-4783-5964
Masako NakanishiCenter for Molecular Oncology, School of Medicine, University of Connecticut, Farmington, Connecticut.ORCID 0000-0002-2170-5216
Daniel W RosenbergCenter for Molecular Oncology, School of Medicine, University of Connecticut, Farmington, Connecticut.ORCID 0000-0003-2897-2613

Funding

Microbiota, Metabolites, and Colon NeoplasiaR01CA252045 · NCI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI JOBIN, CHRISTIAN, ROSENBERG, DANIEL WILLIAM · 2021 to 2025
$3.1M
Computational approaches to the mechanistic elucidation of the serrated pathway of human colon carcinogenesisK25CA270079 · NCI · UNIVERSITY OF OKLAHOMA · PI Marmar Moussa · 2023 to 2026
$795k
American Institute for Cancer Research (AICR) 586610California Walnut Commission (CWC) 586610National Cancer Institute (NCI) CA252045National Cancer Institute (NCI) CA270079National Science Foundation (NSF) 2341725NCI NIH HHS K25 CA270079NCI NIH HHS R01 CA252045
6 · The paper itself

Abstract

Diet affects cancer risk, and plant-derived polyphenols exhibit cancer-preventive properties. Walnuts are an exceptional source of polyphenolic ellagitannins, converted into urolithins by gut microflora. This clinical study examines the impact of urolithin metabolism on inflammatory markers in blood and colon polyp tissue. We evaluate the effects of walnut consumption on urinary urolithins, serum inflammatory markers, and immune cell markers in polyp tissues obtained from 39 subjects. Together with detailed food frequency data, we perform integrated computational analysis of metabolomic data combined with serum inflammatory markers and spatial imaging of polyp tissues using imaging mass cytometry. LC/MS-MS analyses of urine and fecal samples identify a widely divergent capacity to form nine urolithin metabolites in this patient population. Subjects with higher urolithin A formation exhibit lower levels of several key serologic inflammatory markers, including C-peptide, soluble form of intracellular adhesion molecule 1, sIL-6R, ghrelin, TRAIL, sVEGFR2, platelet-derived growth factor (PDGF), and MCP-2, alterations that are more pronounced in obese individuals for soluble form of intracellular adhesion molecule 1, epithelial neutrophil-activating peptide 78, leptin, glucagon-like peptide 1, and macrophage inflammatory protein 1δ. There is a significant increase in levels of peptide YY associated with urolithin A formation, whereas TNFα levels show an opposite trend, recapitulated in an in vitro system with ionomycin/phorbol 12-myristate 13-acetate-stimulated peripheral blood mononuclear cells (PBMC). Spatial imaging of colon polyp tissues shows altered cell cluster patterns, including a significant reduction of vimentin and CD163 expression associated with urolithin A. The ability to form urolithin A is linked to inflammation, warranting further studies to understand the role of urolithins in cancer prevention. Prevention Relevance: We evaluate cancer-protective effects of walnuts via formation of microbe-derived urolithin A, substantiating their functional benefits on serum inflammatory markers and immunologic composition of polyps in normal/obese subjects. Our approach incorporates personalized nutrition within the context of colonic health, providing the rationale for dietary inclusion of walnut ellagitannins for cancer prevention.

Indexed as

ColonColonic PolypsCoumarinsInflammationTumor MicroenvironmentAdultAgedFemaleGastrointestinal MicrobiomeHumansJuglansMaleMiddle Aged3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneCoumarins

Identifiers

PMID39995164
PMCPMC11979956

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.